Taysha Gene Therapies, Inc. TSHA Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Taysha Gene Therapies, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s operating margin?
- Taysha Gene Therapies, Inc. (TSHA) reported operating margin of -1,774.4% in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s operating margin changed year-over-year?
- Taysha Gene Therapies, Inc.'s operating margin decreased by 44.8% year-over-year, from -1,225.8% to -1,774.4%.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s operating margin?
- Over 3 years (2022 to 2025), Taysha Gene Therapies, Inc.'s operating margin has grown at a -44.2% compound annual growth rate (CAGR), from -6,492.7% to -1,130.6%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.